Teriparatide subcutaneous injection – Alvogen — Medical Mutual

Initial criteria

• Patient has tried Natpara AND
• Natpara not available AND
• Age ≥ 18 years AND
• Prescribed by or in consultation with endocrinologist AND
• Patient responding to therapy (e.g. reduction in calcium or vitamin D dose, maintenance of stable albumin-corrected serum calcium concentration)

Reauthorization criteria

• Patient is responding to therapy (e.g. reduction in oral calcium dose, reduction in active vitamin D dose, maintenance of stable albumin-corrected total serum calcium concentration)

Approval duration

1 year (initial and reauth); total max 2 years lifetime